» Articles » PMID: 15930293

BRCA2 Suppresses Cell Proliferation Via Stabilizing MAGE-D1

Overview
Journal Cancer Res
Specialty Oncology
Date 2005 Jun 3
PMID 15930293
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer. BRCA2 is a protein of multiple functions. In addition to its role in DNA double-strand break repair, BRCA2 also plays a role in stabilization of stalled DNA replication forks, cytokinesis, transcription regulation, mammalian gametogenesis, centrosome duplication, and suppression of cell proliferation. However, how BRCA2 mutations predispose women specifically to breast and ovarian cancer remains undefined. Here we found that BRCA2 binds and stabilizes MAGE-D1, a member of the MAGE gene family of proteins. Expression of BRCA2 and MAGE-D1 synergistically suppresses cell proliferation independently of the p53 pathway. Using two MAGE-D1 RNA interferences and two cell lines expressing low or undetectable levels of MAGE-D1, we further showed that the expression of MAGE-D1 is required for BRCA2-mediated suppression of cell proliferation, indicating that MAGE-D1 is a downstream target of BRCA2 and that BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Importantly, MAGE-D1 protein expression was reduced in 6 of 16 breast carcinoma cell lines tested as compared with untransformed immortal mammary epithelial cell lines, suggesting that suppression of MAGE-D1 expression may be involved in the tumorigenesis of a subset of sporadic breast cancers.

Citing Articles

Unique Transcriptomic Changes Underlie Hormonal Interactions During Mammary Histomorphogenesis in Female Pigs.

Trott J, Schennink A, Horigan K, Lemay D, Cohen J, Famula T Endocrinology. 2021; 163(3).

PMID: 34918063 PMC: 10409904. DOI: 10.1210/endocr/bqab256.


Loss of smarcad1a accelerates tumorigenesis of malignant peripheral nerve sheath tumors in zebrafish.

Han H, Jiang G, Kumari R, Silic M, Owens J, Hu C Genes Chromosomes Cancer. 2021; 60(11):743-761.

PMID: 34296799 PMC: 9585957. DOI: 10.1002/gcc.22983.


RNA Methylation: A New Regulator of Vascular Remodeling in Pulmonary Hypertension.

Bonnet S, Gomez D Am J Respir Crit Care Med. 2021; 203(9):1060-1062.

PMID: 33636090 PMC: 8314911. DOI: 10.1164/rccm.202011-4185ED.


Ranking cancer drivers via betweenness-based outlier detection and random walks.

Erten C, Houdjedj A, Kazan H BMC Bioinformatics. 2021; 22(1):62.

PMID: 33568049 PMC: 7877041. DOI: 10.1186/s12859-021-03989-w.


Genetic and molecular bases of esophageal Cancer among Iranians: an update.

Abbaszadegan M, Keyvani V, Moghbeli M Diagn Pathol. 2019; 14(1):97.

PMID: 31470870 PMC: 6717340. DOI: 10.1186/s13000-019-0875-4.


References
1.
Jordan B, Dinev D, LeMellay V, Troppmair J, Gotz R, Wixler L . Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem. 2001; 276(43):39985-9. DOI: 10.1074/jbc.C100171200. View

2.
Wang S, Shao R, Pao A, Zhang S, Hung M, Su L . Inhibition of cancer cell growth by BRCA2. Cancer Res. 2002; 62(5):1311-4. View

3.
Barker P, Salehi A . The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 2002; 67(6):705-12. DOI: 10.1002/jnr.10160. View

4.
Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K . A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem. 2002; 277(25):22541-6. DOI: 10.1074/jbc.M109728200. View

5.
Yang H, Jeffrey P, Miller J, Kinnucan E, Sun Y, Thoma N . BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 2002; 297(5588):1837-48. DOI: 10.1126/science.297.5588.1837. View